Y, T., Y, X., S, Y., F, S., X, L., S, B., . . . SL, S. (2025). Potential Value of AURKA and CDK6 Amplification for the Response of Patients With Gastric Cancer to Neoadjuvant Chemotherapy. Molecular carcinogenesis, 64(7), 1195. https://doi.org/10.1002/mc.23921
Chicago Style (17th ed.) CitationY, Tan, Xing Y, Yuan S, Sun F, Lin X, Bao S, Jiang D, Zhang J, and Sun SL. "Potential Value of AURKA and CDK6 Amplification for the Response of Patients With Gastric Cancer to Neoadjuvant Chemotherapy." Molecular Carcinogenesis 64, no. 7 (2025): 1195. https://doi.org/10.1002/mc.23921.
MLA (9th ed.) CitationY, Tan, et al. "Potential Value of AURKA and CDK6 Amplification for the Response of Patients With Gastric Cancer to Neoadjuvant Chemotherapy." Molecular Carcinogenesis, vol. 64, no. 7, 2025, p. 1195, https://doi.org/10.1002/mc.23921.